Speaker Profile

MBA, CEO, MedySapiens, Inc.

Sanggoo Kang is CEO & founder of MedySapiens, Inc. pursuing perfect harmony of Biomedical and Data Science (Bioinformatics and Artificial Intelligence combined). Previously, Kang was COO/VP at DNA Link, one of the largest genomics service providers in Korea. After getting MBA from Duke in 1999, Kang worked for various companies in the US mostly in Hi-Tech marketing and business development area. They include 3M, Toshiba America, Samsung Electronics America, Nortel Networks and JP Morgan. Before coming to the US, Kang used to work for LG U+ as Telecom Engineer. Kang has Electrical Engineering BS degree from Seoul National University (Seoul, Korea) and MBA from Duke University. Kang has diversified background; Engineering and Business, Information & Communication Technology and Bio Tech, and global exposure.

AI and Data Science Showcase: MedySapiens, Inc.
MedySapiens provides solution to improve human’s Quality of Life thru ultimate harmony of Biomedical & Data Science (Bioinformatics and AI combined).

Cardiovascular Segmentation And Surgery Recommendation Using Deep-Learning
1. Stenosis detection & cardiovascular segmentation from cardio angiogram (dicom-formatted Xray) using deep learning, 2. Surgery recommendation of stent (PCI, Percutaneous Coronary Intervention, aka stent) vs.bypass (CABG, Coronary Artery Bypass Grafting) per Syntax Score.

Don't Miss Important Precision Medicine Updates

PMWC is the most comprehensive precision medicine conference. To receive the lastest news and updates from the field, subscribe to the newsletter here.

View the top 3 talks from PMWC here (password: top-videos).